$10.258
0.133[1.31%]
At close: Apr 25
$10.258
0[0.00%]
PreMarket: 6:50PM EDT
Inovio Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Inovio Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/08/2024 | PM | INO | Q1 | -$1.92 | -$0.99 | — | — | $114.94K | $190.00K | — | — | Get Alert |
03/06/2024 | AM | INO | Q4 | -$2.64 | -$1.27 | -$1.10 | 13.39% | $125.00K | $340.00K | $103.00K | -69.71% | Get Alert |
11/09/2023 | PM | INO | Q3 | -$1.80 | -$1.56 | -$1.56 | 0.00% | $9.15M | $120.00K | $388.45K | 223.71% | Get Alert |
08/09/2023 | PM | INO | Q2 | -$5.52 | -$1.68 | -$1.56 | 7.14% | $784.39K | $260.00K | $225.97K | -13.09% | Get Alert |
05/10/2023 | PM | INO | Q1 | -$4.32 | -$1.68 | -$1.92 | -14.29% | $199.07K | $270.00K | $114.94K | -57.43% | Get Alert |
03/01/2023 | PM | INO | Q4 | -$6.00 | -$2.04 | -$2.64 | -29.41% | $839.00K | $340.00K | $125.00K | -63.24% | Get Alert |
11/08/2022 | PM | INO | Q3 | -$3.48 | -$3.60 | -$1.80 | 50.00% | $291.70K | $620.00K | $9.15M | 1376.45% | Get Alert |
08/09/2022 | PM | INO | Q2 | -$4.68 | -$3.72 | -$5.52 | -48.39% | $272.82K | $520.00K | $784.39K | 50.85% | Get Alert |
05/10/2022 | PM | INO | Q1 | -$3.24 | -$4.08 | -$4.32 | -5.88% | $371.12K | $670.00K | $199.07K | -70.29% | Get Alert |
03/01/2022 | PM | INO | Q4 | -$1.68 | -$3.84 | -$6.00 | -56.25% | $5.58M | $2.84M | $839.00K | -70.46% | Get Alert |
11/09/2021 | PM | INO | Q3 | -$3.12 | -$3.96 | -$3.48 | 12.12% | $236.18M | $970.00K | $291.70K | -69.93% | Get Alert |
08/09/2021 | PM | INO | Q2 | -$2.40 | -$3.00 | -$4.68 | -56.00% | $267.19K | $1.21M | $272.82K | -77.45% | Get Alert |
05/10/2021 | PM | INO | Q1 | -$3.12 | -$2.16 | -$3.24 | -50.00% | $1.33M | $850.00K | $371.12K | -56.34% | Get Alert |
03/01/2021 | PM | INO | Q4 | -$4.56 | -$2.64 | -$1.68 | 36.36% | $279.00K | $1.11M | $5.58M | 402.79% | Get Alert |
11/09/2020 | PM | INO | Q3 | -$3.00 | -$2.28 | -$3.12 | -36.84% | $866.86K | $3.05M | $236.18M | 7643.54% | Get Alert |
08/10/2020 | PM | INO | Q2 | -$3.60 | -$2.04 | -$2.40 | -17.65% | $135.67K | $2.61M | $267.19K | -89.76% | Get Alert |
05/11/2020 | PM | INO | Q1 | -$3.60 | -$2.64 | -$3.12 | -18.18% | $2.83M | $1.91M | $1.33M | -30.52% | Get Alert |
03/12/2020 | PM | INO | Q4 | -$4.08 | -$2.88 | -$4.56 | -58.33% | $2.50M | $2.32M | $279.00K | -87.97% | Get Alert |
11/12/2019 | PM | INO | Q3 | -$3.24 | -$3.12 | -$3.00 | 3.85% | $2.00M | $3.93M | $866.86K | -77.94% | Get Alert |
Inovio Pharmaceuticals (INO) is scheduled to report earnings on May 8, 2024. The last reported earnings were for reported on March 6, 2024 for Q4.
The Actual EPS was $-1.10, which beat the estimate of $-1.27.
The Actual Revenue was $103K, which missed the estimate of $340K.
Browse earnings estimates, EPS, and revenue on all stocks.